全身或鼓室內(nèi)應(yīng)用激素治療突發(fā)性耳聾的療效及預(yù)后影響因素研究
發(fā)布時間:2018-10-31 20:01
【摘要】:目的:觀察全身或鼓室內(nèi)注射類固醇激素治療突發(fā)性聾的療效,比較鼓室內(nèi)注射(初始治療)與全身使用激素后再鼓室內(nèi)注射(補(bǔ)充治療)的療效,探討分析影響突發(fā)性聾預(yù)后的相關(guān)因素。 方法:回顧性分析被確診為突發(fā)性聾的156例患者,其中初始治療組78例和全身+補(bǔ)充治療(全身使用激素后再鼓室內(nèi)注射78例。初始治療組注射類固醇激素1次/d,1周為1療程,1-4療程;全身+補(bǔ)充治療組全身靜滴類固醇激素,10d后改為鼓室內(nèi)給藥。兩組同時靜滴丹參(16ml/d),加或不加高壓氧治療。治療前和治療后每周復(fù)查純音測聽(pure tone average,PTA)。隨訪3個月。 結(jié)果:按PTA恢復(fù)≥15dBHL為有效,初始治療有效率73.1%,全身+補(bǔ)充治療有效率為53.8%,經(jīng)χ2檢驗,差異有統(tǒng)計學(xué)意義(P<0.05)。按PTA恢復(fù)≥10dBHL為有效,初始治療76.9%,全身+補(bǔ)充治療為64.1%,經(jīng)χ2檢驗,差異無統(tǒng)計學(xué)意義(P㧐0.05)。預(yù)后相關(guān)因素分析表明:患者性別、年齡、治療前聽力水平及激素的兩種治療方式與預(yù)后無明顯相關(guān)性(P㧐0.05)。初診時間、伴耳鳴、眩暈、聽力圖類型及高壓氧治療等因素與預(yù)后相關(guān)。從初診時間上來看,初診時間3d有效率為73.0%,3-7d有效率為69.4%,7-14d有效率為44.4%,14d有效率為36.4%,3d與3-7d相比較,療效分別為73.0%和69.4%,差異無統(tǒng)計學(xué)意義(P㧐0.05),7-14d與14d以上相比較,差異無統(tǒng)計學(xué)意義(P㧐0.05),7d以內(nèi)和7d以上比較,差異有統(tǒng)計學(xué)意義(P<0.05)。從耳鳴來看,伴耳鳴有效率44.4%,,無耳鳴有效率71.2%,差異有統(tǒng)計學(xué)意義(P<0.05)。從眩暈來看,伴眩暈有效率49.3%,無眩暈有效率74.2%,差異有統(tǒng)計學(xué)意義(P<0.05)。從聽力圖類型上看,上升型(低頻型)、平坦型、下降型(高頻型)和全聾型有效率分別為64.9%、56.6%、55.6%、50.0%,上升型的有效率與其它型相比,差異有統(tǒng)計學(xué)意義(P<0.05)。從高壓氧治療來看,同時給予高壓氧治療有效率74.2%,無高壓氧治療有效率55.0%,差異有統(tǒng)計學(xué)意義(p0.05),同時給予高壓氧治療療效好。 結(jié)論:全身或鼓室內(nèi)注射類固醇激素治療突發(fā)性聾均有效。初始鼓室內(nèi)注射類固醇激素能達(dá)到或超過全身治療的效果,鼓室內(nèi)注射類固醇激素是一種安全、耐受性良好的治療突發(fā)性聾的方式,可以把初始治療作為首選治療。發(fā)病到治療1周后預(yù)后差。不同的聽力圖類型是影響突發(fā)性聾預(yù)后的重要因素,上升型預(yù)后好。伴有耳鳴、眩暈的患者預(yù)后較差。藥物治療同時給予高壓氧治療療效好。
[Abstract]:Objective: to observe the effect of systemic or intratympanic steroid injection in the treatment of sudden deafness, and to compare the efficacy of intratympanic injection (initial treatment) with that of systemic steroid injection (supplementary therapy). Objective: to investigate the factors related to the prognosis of sudden deafness. Methods: 156 patients with sudden deafness were analyzed retrospectively, including 78 cases in the initial treatment group and 78 cases in the systemic supplementation group. In the initial treatment group, steroid hormone was injected once a week for a course of treatment, 1-4 courses of treatment, and systemic infusion of steroid hormone was changed to intratympanic administration after 10 days in the whole body supplementation group. In both groups, salvia miltiorrhiza (16ml/d) was given intravenously with or without hyperbaric oxygen. Pure tone audiometry (pure tone average,PTA) was performed before and after treatment. Follow-up for 3 months. Results: according to the recovery of PTA 鈮
本文編號:2303383
[Abstract]:Objective: to observe the effect of systemic or intratympanic steroid injection in the treatment of sudden deafness, and to compare the efficacy of intratympanic injection (initial treatment) with that of systemic steroid injection (supplementary therapy). Objective: to investigate the factors related to the prognosis of sudden deafness. Methods: 156 patients with sudden deafness were analyzed retrospectively, including 78 cases in the initial treatment group and 78 cases in the systemic supplementation group. In the initial treatment group, steroid hormone was injected once a week for a course of treatment, 1-4 courses of treatment, and systemic infusion of steroid hormone was changed to intratympanic administration after 10 days in the whole body supplementation group. In both groups, salvia miltiorrhiza (16ml/d) was given intravenously with or without hyperbaric oxygen. Pure tone audiometry (pure tone average,PTA) was performed before and after treatment. Follow-up for 3 months. Results: according to the recovery of PTA 鈮
本文編號:2303383
本文鏈接:http://sikaile.net/yixuelunwen/yank/2303383.html
最近更新
教材專著